March 13 (Reuters) - Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known...
March 13 (Reuters) - Boston Scientific Corp said the U.S. Food and Drug Administration on Friday approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation.
BRUSSELS, March 5 (Reuters) - U.S. medical device maker Boston Scientific Corp 's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.
We are not surprised by Boston Scientific 's impending purchase of Endo International's urology and prostate health businesses, and at first blush, we are leaving our
March 2 (Reuters) - Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.
March 2 (Reuters) - Boston Scientific Corp said it will acquire Endo International Plc's American Medical Systems urology portfolio for up to $1.65 billion.
pharmaceutical company. Endo is selling its men’s health and prostate segments of its AMS device business to Boston Scientific for $1.65 billion. The AMS business, which was acquired under the previous Endo management in 2011, has largely
Vendors GE Healthcare Phillips Healthcare Siemens Healthcare Toshiba Medical Systems Other Prominent Vendors Analogic Boston Scientific Carestream Health Esaote Fujifilm Medical Hitachi Medical Mindray Medical Samsung Medison St. Jude Medical TomTec
Feb 17 (Reuters) - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific 's 2005 acquisition of rival Guidant.
CHICAGO, February 17 (Fitch) Boston Scientific Corp .'s (NYSE: BSX ) ratings are unaffected by its ..... regarding litigation associated with BSX 's acquisition of Guidant in ..... Ratings. The settlement calls for BSX to pay $600 million to JNJ during